Octyl acetate is a straight-chain aliphatic ester found in selected essential oils and other natural volatile mixtures, including frankincense materials in the AromaForge archive. The strongest accessible evidence is for chemical identity, odor-threshold behavior, occurrence in some aromatic plants, and modern fragrance-safety review rather than for direct wellness effects. The current public literature supports describing octyl acetate mainly as an aroma and composition marker with preclinical toxicology and fragrance-assessment context, not as a validated therapeutic active.
Chemical identity and composition
PubChem identifies octyl acetate as CID 8164 with molecular formula C10H20O2 and IUPAC name octyl acetate. PubChem synonym records also support common names including n-octyl acetate, octyl ethanoate, and acetic acid, octyl ester. In the AromaForge archive it is currently a minor quantified constituent in frankincense, while older fragrance and sensory literature treats it as one member of the homologous acetate series used in odor-threshold and safety work.
Aroma and practical use
- Use the recorded fruity, orange-like, waxy, green, fatty descriptors to explore a blend's scent character; perceived strength also depends on the other ingredients.
- Review the flagged use concerns across every contributing oil and the selected dilution.
- Read the route, preparation and experimental context before using a study finding to choose an oil.
Reported benefits and effects
Findings retain their study context. An animal or laboratory result describes that experiment.
A psychophysical study of homologous n-acetates reported measurable odor-detection functions for octyl acetate, supporting its role as a low-level but detectable odorant within ester series comparisons.
A psychophysical study of homologous n-acetates reported measurable odor-detection functions for octyl acetate, supporting its role as a low-level but detectable odorant within ester series comparisons.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
A developmental toxicology study in rats reported some evidence of developmental toxicity only at a maternally toxic oral dose of 1.0 g/kg, indicating that the accessible toxicology signal is high-dose preclinical rather than use-level fragrance evidence.
A developmental toxicology study in rats reported some evidence of developmental toxicity only at a maternally toxic oral dose of 1.0 g/kg, indicating that the accessible toxicology signal is high-dose preclinical rather than use-level fragrance evidence.
This experimental finding does not establish benefit, dose or safety in people using this blend.
A 2024 RIFM update for octyl acetate indicates that the ingredient has an active modern fragrance-safety assessment record rather than being an unreviewed material.
A 2024 RIFM update for octyl acetate indicates that the ingredient has an active modern fragrance-safety assessment record rather than being an unreviewed material.
The source assessment applies to its specified exposure and preparation; this entry is not an unrestricted-use clearance.
A 2022 frankincense comparison paper found octyl acetate at about 0.9-1.0% in the two lab-distilled Boswellia carteri samples it reported, supporting archive use as a real but minor frankincense constituent.
A 2022 frankincense comparison paper found octyl acetate at about 0.9-1.0% in the two lab-distilled Boswellia carteri samples it reported, supporting archive use as a real but minor frankincense constituent.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
Use concerns and concentration limits
Sensitization concernFlagged
Flagged in the constituent reference; assess the source, route and finished-product concentration.
Phototoxicity concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Oxidation concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Penetration enhancementNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
A recorded constituent reference, not a recommended oil dilution. Product category, source applicability and all contributing oils must be checked before use.
unverified reference · No source provenance attachedA current RIFM fragrance ingredient safety assessment update exists for octyl acetate, which is the strongest directly relevant modern safety source verified in this pass.
The source assessment applies to its specified exposure and preparation; this entry is not an unrestricted-use clearance.
No direct public citation is attached to this entry.
The directly accessible constituent-specific toxicology literature located in this pass is preclinical and includes high-dose animal work, so it should not be translated into consumer-use medical claims.
This experimental finding does not establish benefit, dose or safety in people using this blend.
No direct public citation is attached to this entry.
Constituents it may interact with
No constituent-pair interaction is recorded for this identity. The report does not assume either amplification or incompatibility.
How the effects were investigated
chain length dependent odor detection
Sensory literature on homologous n-acetates shows that octyl acetate participates in chain-length-dependent odor detection behavior, reinforcing its primary archive relevance as an odorant rather than a bioactive pathway driver.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
What this report cannot establish
- A reported constituent percentage does not establish an effective human therapeutic dose or the amount absorbed into the body.
- The presence of a constituent does not guarantee a clinical benefit, rash treatment or sleep improvement from a custom blend.
- An unflagged concern or missing use limit does not establish safety for ingestion, inhalation, skin exposure or a particular person.
- A candidate constituent interaction does not establish that two oils amplify one another at the selected proportions.
- Constituent descriptors alone do not establish a precise top, heart or base lifetime in a finished blend.
Known data gaps (5)
- This pass did not verify human clinical outcome literature specific to isolated octyl acetate.
- A constituent-specific dermal maximum or inhalation-use framework for octyl acetate was not verified from open sources in this pass.
- Most accessible literature concerns odor science, occurrence, or toxicology rather than direct mechanism-of-action biology.
- The numeric dermal reference lacks source provenance; a verified flag alone is insufficient.
- Some findings do not record an explicit exposure route; consult the linked study before applying them to a use.